![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1765458
¼¼°èÀÇ º¥Ãò¸® ¸¶½ºÅ© ½ÃÀåVenturi Masks |
º¥Ãò¸® ¸¶½ºÅ© ¼¼°è ½ÃÀåÀº 2030³â±îÁö 59¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á
2024³â¿¡ 31¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â º¥Ãò¸® ¸¶½ºÅ© ¼¼°è ½ÃÀåÀº 2024-2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 11.5%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 59¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼¿¡¼ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ COPD´Â CAGR 13.5%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 29¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. õ½Ä ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 10.3%·Î ÃßÁ¤µË´Ï´Ù.
¹Ì±¹ ½ÃÀåÀº 7¾ï 7,810¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 15.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø
¹Ì±¹ÀÇ º¥Ãò¸® ¸¶½ºÅ© ½ÃÀåÀº 2024³â¿¡ 7¾ï 7,810¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 15¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 15.7%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 7.3%¿Í 9.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼´Â µ¶ÀÏÀÌ CAGR ¾à 8.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ º¥Ãò¸® ¸¶½ºÅ© ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®
º¥Ãò¸® ¸¶½ºÅ©´Â ¹«¾ùÀΰ¡?
º¥Ãò¸® ¸¶½ºÅ©´Â È£Èí±âÁúȯ ȯÀÚ¿¡°Ô Á¤È®ÇÑ ³óµµÀÇ »ê¼Ò¸¦ °ø±ÞÇϱâ À§ÇØ ¼³°èµÈ ÀÇ·á±â±âÀÔ´Ï´Ù. ÀϹÝÀûÀÎ »ê¼Ò ¸¶½ºÅ©¿Í ´Þ¸® º¥Ãò¸® ¸¶½ºÅ©´Â º¥Åõ¸® È¿°ú¸¦ ÀÌ¿ëÇÑ µ¶Æ¯ÇÑ µðÀÚÀÎÀ¸·Î ÁÖº¯ °ø±â¿Í »ê¼Ò¸¦ È¥ÇÕÇÏ¿© ȯÀÚÀÇ Çʿ信 µû¶ó »ê¼Ò ³óµµ¸¦ Á¶ÀýÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼ ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), õ½Ä, ±âŸ È£Èí±âÁúȯ µî ƯÁ¤ ÈíÀÔ »ê¼Ò ³óµµ(FiO2)°¡ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô ƯÈ÷ È¿°úÀûÀÔ´Ï´Ù. Á¤È®ÇÑ »ê¼Ò ³óµµ¸¦ Á¦°øÇÒ ¼ö Àֱ⠶§¹®¿¡ º¥Ãò¸® ¸¶½ºÅ©´Â º´¿øÀ̳ª ¿Ü·¡ Áø·á ½Ã¼³°ú °°Àº ÀÓ»ó ÇöÀå¿¡¼ ¼±Åõǰí ÀÖ½À´Ï´Ù.
º¥Ãò¸® ¸¶½ºÅ©ÀÇ Á¦Á¶¿¡´Â °¡º±°í ³»±¸¼ºÀÌ ¶Ù¾î³ ÇÃ¶ó½ºÆ½À¸·Î ¸¸µé¾îÁø ¸¶½ºÅ© º»Ã¼¿Í »ê¼Ò À¯·®À» °áÁ¤ÇÏ´Â ´Ù¾çÇÑ »ö»óÀÇ ¾î´ðÅͰ¡ Æ÷ÇԵ˴ϴÙ. °¢ ¾î´ðÅÍ¿¡´Â ƯÁ¤ ¿À¸®Çǽº Å©±â°¡ ÀÖ¾î °ø±ÞµÇ´Â »ê¼Ò¿¡ ´Ù¸¥ ¾çÀÇ ÁÖº¯ °ø±â¸¦ È¥ÇÕÇÒ ¼ö ÀÖ½À´Ï´Ù. µðÀÚÀÎÀº ȯÀÚÀÇ ¾ó±¼À» ´Ü´ÜÈ÷ ¹ÐÆóÇÏ¿© »ê¼ÒÀÇ È帧À» ÃËÁøÇÏ°í ¼ûÀ» ³»½¬´Â µ¿¾È ¼ûÀÌ »õÁö ¾Êµµ·Ï ÇØ¾ß ÇÕ´Ï´Ù. ¸¶½ºÅ©´Â ÀϹÝÀûÀ¸·Î »çÃâ ¼ºÇü °øÁ¤À¸·Î Á¦Á¶µÇ¸ç, Á¦Á¶¾÷ü´Â ¾ö°ÝÇÑ ÀÇ·á Ç¥ÁØÀ» ÃæÁ·ÇÏ´Â ±ÕÀÏÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ºÎǰÀ» ¸¸µé ¼ö ÀÖ½À´Ï´Ù.
ÃÖ±Ù º¥Ãò¸® ¸¶½ºÅ© ¼³°è ¹× Á¦Á¶ÀÇ ¹ßÀüÀº ȯÀÚÀÇ Æí¾ÈÇÔÀ» °³¼±Çϰí, »ê¼Ò °ø±Þ È¿À²À» ³ôÀ̸ç, ³»±¸¼ºÀ» À¯ÁöÇÏ¸é¼ ¹«°Ô¸¦ ÁÙÀÌ´Â ÃֽмÒÀ縦 ÅëÇÕÇÏ´Â µ¥ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. Çõ½ÅÀûÀÎ ±â¼ú¿¡´Â ¾ó±¼¿¡ ´õ Àß ¹ÐÂøµÇ°í ¹ÐÆóµÇ¾î Àå½Ã°£ »ç¿ë¿¡µµ Àü¹ÝÀûÀÎ Æí¾ÈÇÔÀ» Çâ»ó½ÃŰ´Â ºÎµå·¯¿î ½Ç¸®ÄÜ ¶Ç´Â Á© ¶óÀ̳ʰ¡ Æ÷ÇԵ˴ϴÙ. ¶ÇÇÑ, ¸¶½ºÅ©ÀÇ Àå±â »ç¿ëÀ¸·Î ÀÎÇÑ °¨¿° À§ÇèÀ» ÁÙÀ̱â À§ÇØ Ç×±Õ ¼ÒÀçÀÇ »ç¿ëµµ °í·ÁµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º¸´Ù ÄÄÆÑÆ®Çϰí ÈÞ´ë°¡ °£ÆíÇÑ º¥Ãò¸® ¸¶½ºÅ©ÀÇ °³¹ß µ¿Çâµµ ÀÖ¾î ÀçÅà °£È£ ȯ°æ µî ´Ù¾çÇÑ »óȲ¿¡¼ »ç¿ëÇÏ±â Æí¸®ÇØÁö°í ÀÖ½À´Ï´Ù.
º¥Ãò¸® ¸¶½ºÅ©ÀÇ ÁÖ¿ä ¿ëµµ´Â?
º¥Ãò¸® ¸¶½ºÅ©´Â ÁÖ·Î ÇコÄÉ¾î »ê¾÷, ƯÈ÷ º´¿ø, ¿Ü·¡ Áø·á¼Ò, ÀçÅà °£È£ ÇöÀå¿¡¼ È£Èí±âÁúȯ ȯÀÚ °ü¸®¿¡ »ç¿ëµË´Ï´Ù. º¥Ãò¸® ¸¶½ºÅ©ÀÇ ÁÖ¿ä ¿ëµµ Áß Çϳª´Â ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD) ȯÀÚÀÇ Ä¡·á¿¡¼ ÃÖÀûÀÇ »ê¼Ò ³óµµ¸¦ À¯ÁöÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. º¥Ãò¸® ¸¶½ºÅ©´Â Á¶ÀýµÈ ³óµµÀÇ »ê¼Ò¸¦ °ø±ÞÇÏ¿© Áõ»ó ¾Çȸ¦ ¹æÁöÇϰí, ȯÀÚÀÇ È£ÈíÀ» Æí¾ÈÇÏ°Ô Çϸç, Àü¹ÝÀûÀÎ »îÀÇ ÁúÀ» Çâ»ó½Ãŵ´Ï´Ù. ÀÌ·¯ÇÑ Á¤È®ÇÑ »ê¼Ò °ø±ÞÀº Àú»ê¼ÒÁõ ¹× °í»ê¼ÒÁõ°ú °ü·ÃµÈ À§ÇèÀ» °¨¼Ò½ÃÄÑ º¥Ãò¸® ¸¶½ºÅ©´Â COPD °ü¸®¿¡ ÇʼöÀûÀÎ µµ±¸°¡ µË´Ï´Ù.
ÀÀ±ÞÀÇ·á ÇöÀå¿¡¼ º¥Ãò¸® ¸¶½ºÅ©´Â ±Þ¼º È£Èí°ï¶õÀ̳ª õ½Ä ¹× Æó·ÅÀÌ ¾ÇÈµÈ È¯ÀÚ¿¡°Ô »ê¼Ò ¿ä¹ýÀ» Á¦°øÇϱâ À§ÇØ »ç¿ëµË´Ï´Ù. ƯÁ¤ »ê¼Ò ³óµµ¸¦ ºü¸£°í È¿°úÀûÀ¸·Î °ø±ÞÇÒ ¼ö ÀÖ´Â ´É·ÂÀº ½Å¼ÓÇÑ °³ÀÔÀÌ È¯ÀÚÀÇ ¿¹ÈÄ¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡´Â ÀÀ±Þ ÀÇ·á ÇöÀå¿¡¼ ÇʼöÀûÀÔ´Ï´Ù. º¥Ãò¸® ¸¶½ºÅ©´Â »ê¼Ò ¿ä¹ýÀÌ ÇÊ¿äÇÑ È¯ÀÚ¸¦ À̼ÛÇÒ ¶§¿¡µµ »ç¿ëµË´Ï´Ù. º¹ÀâÇÑ ÀåÄ¡ ¾øÀ̵µ ¾ÈÁ¤ÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â »ê¼Ò °ø±Þ¿øÀ» Á¦°øÇϱ⠶§¹®ÀÔ´Ï´Ù. µû¶ó¼ ±¸±ÞÂ÷³ª ÁßȯÀÚ ÀÌ¼Û ¼ºñ½º¿¡¼ ¸Å¿ì ±ÍÁßÇÑ ÀÚ»êÀÌ µÇ°í ÀÖ½À´Ï´Ù.
¶ÇÇÑ, º¥Ãò¸® ¸¶½ºÅ©´Â ¸¸¼º È£Èí±âÁúȯÀ» ¾Î°í Àִ ȯÀÚµéÀ» ´ë»óÀ¸·Î ÇÑ ÀçÅÃÀÇ·á¿¡¼µµ Ȱ¿ëµµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀçÅÃÀǷḦ ¹Þ´Â »ç¶÷µéÀÌ ´Ã¾î³²¿¡ µû¶ó ÈÞ´ë°¡ °£ÆíÇÏ°í »ç¿ëÇϱ⠽¬¿î »ê¼Ò °ø±Þ ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º¥Ãò¸® ¸¶½ºÅ©´Â »ê¼Ò ³óµµ¸¦ Á¤È®ÇÏ°Ô Á¶ÀýÇÒ ¼ö ÀÖ¾î ȯÀÚ°¡ ÀÇ·á±â°üÀ» ÀÚÁÖ ¹æ¹®ÇÏÁö ¾Ê°íµµ È£Èí±âÁúȯÀ» È¿°úÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ¾î ÀçÅÃÀÇ·á¿¡¼ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °í·ÉÈ Àα¸ÀÇ Áõ°¡°¡ ÀçÅÃÀÇ·á¿¡¼ º¥Ãò¸® ¸¶½ºÅ©ÀÇ Ã¤Åà Ȯ´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
º¥Ãò¸® ¸¶½ºÅ©´Â È£Èí±âÁúȯ¿¡ ´ëÇÑ »õ·Î¿î Ä¡·á¹ý°ú Ä¡·á¹ýÀ» Æò°¡Çϱâ À§ÇÑ Á¶»ç ¹× ÀÓ»ó ¿¬±¸¿¡µµ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. Á¦¾îµÈ »ê¼Ò ³óµµ¸¦ °ø±ÞÇÒ ¼ö Àֱ⠶§¹®¿¡ ¿¬±¸ÀÚµéÀº ´Ù¾çÇÑ È£Èí±âÁúȯ°ú Ä¡·á¿¡ ´ëÇÑ ´Ù¾çÇÑ »ê¼Ò ³óµµÀÇ È¿°ú¸¦ Á¶»çÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ëµµ´Â ÀÇ·á°è°¡ ¸¸¼ºÁúȯÀÇ ÃÖÀû °ü¸®¿Í »õ·Î¿î Ä¡·á¹ý °³¹ßÀ» À§ÇØ ³ë·ÂÇϰí ÀÖ´Â »óȲ¿¡¼ ƯÈ÷ Áß¿äÇÕ´Ï´Ù.
º¥Ãò¸® ¸¶½ºÅ©¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?
º¥Ãò¸® ¸¶½ºÅ©ÀÇ ¼ö¿ä´Â È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡, °ü¸®Çü »ê¼Ò ¿ä¹ýÀÇ Á߿伺¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀçÅÃÀÇ·á ¼ºñ½º È®´ë µî ¿©·¯ ¿äÀο¡ ÀÇÇØ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼ö¿ä Áõ°¡ÀÇ ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â COPD, õ½Ä µî ¸¸¼º È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Áõ»óÀÌ Æ¯È÷ ³ëÀÎµé »çÀÌ¿¡¼ È®»êµÊ¿¡ µû¶ó »ê¼Ò ³óµµ¸¦ Á¤È®ÇÏ°Ô Á¦¾îÇÒ ¼ö ÀÖ´Â È¿°úÀûÀÎ »ê¼Ò °ø±Þ ½Ã½ºÅÛÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º¥Ãò¸® ¸¶½ºÅ©´Â Ç¥ÀûÈµÈ »ê¼Ò ¿ä¹ýÀ» Á¦°øÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ¸¸¼ºÁúȯÀ» °ü¸®ÇÏ´Â µ¥ ÇʼöÀûÀÎ µµ±¸°¡ µÉ ¼ö ÀÖ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.
ȯÀÚ Áß½É Ä¡·á¿¡ ´ëÇÑ °Á¶¿Í ÃÖÀûÀÇ »ê¼Ò Æ÷ȵµ¸¦ À¯ÁöÇÏ´Â °ÍÀÇ Á߿伺ÀÌ ³ô¾ÆÁö¸é¼ º¥Ãò¸® ¸¶½ºÅ©¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦°øÀÚµéÀº »ê¼Ò ºÎÁ· ¹× »ê¼Ò °úÀ×°ú °ü·ÃµÈ ÇÕº´ÁõÀÇ À§ÇèÀ» ÃÖ¼ÒÈÇϱâ À§ÇØ ÅëÁ¦µÈ »ê¼Ò ¿ä¹ýÀ» Á¦°øÇÏ´Â °ÍÀÇ °¡Ä¡¸¦ Á¡Á¡ ´õ ¸¹ÀÌ ÀνÄÇϰí ÀÖ½À´Ï´Ù. º¥Ãò¸® ¸¶½ºÅ©´Â Á¤È®Çϰí Á¶Àý °¡´ÉÇÑ »ê¼Ò ³óµµ¸¦ Á¦°øÇÒ ¼ö ÀÖ¾î ÀÓ»ó ÇöÀå¿¡¼ ¼±È£µÇ´Â ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. »ê¼Ò ³óµµ Á¶ÀýÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó º¥Ãò¸® ¸¶½ºÅ©ÀÇ Ã¤ÅÃÀÌ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ, ÀçÅÃÀÇ·á ¼ºñ½ºÀÇ È®´ë°¡ º¥Ãò¸® ¸¶½ºÅ©ÀÇ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. Áý¿¡¼ Ä¡·á¸¦ ¹Þ´Â ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó È£Èí±âÁúȯÀ» È¿°úÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ´Â ÈÞ´ë°¡ °£ÆíÇÏ°í »ç¿ëÇϱ⠽¬¿î ÀÇ·á±â±â¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º¥Ãò¸® ¸¶½ºÅ©´Â Á¦¾îµÈ »ê¼Ò ¿ä¹ýÀ» Á¦°øÇÏ´Â ´Ü¼ø¼º°ú ½Å·Ú¼ºÀ¸·Î ÀÎÇØ ÀçÅÃÀÇ·á¿¡ ÀûÇÕÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â COVID-19 ÆÒµ¥¹Í(¼¼°èÀû ´ëÀ¯Çà)¿¡ ºñÃß¾î º¼ ¶§ ƯÈ÷ Áß¿äÇϸç, ÀÌ·Î ÀÎÇØ Áý¿¡¼ °ü¸®µÇ´Â ȯÀÚ ¼ö°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ȨÄɾî ȯ°æ¿¡¼ È¿°úÀûÀÎ »ê¼Ò °ø±Þ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ º¥Ãò¸® ¸¶½ºÅ© ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¥Ãò¸® ¸¶½ºÅ©¿¡ »ç¿ëµÇ´Â µðÀÚÀΰú ¼ÒÀçÀÇ ±â¼úÀû Áøº¸µµ Àα⠻ó½Â¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Á¦Á¶¾÷üµéÀº ´õ Æí¾ÈÇÏ°í °¡º±°í »ç¿ëÇϱ⠽¬¿î ¸¶½ºÅ©¸¦ °³¹ßÇÏ¿© ȯÀÚ¿Í ÀÇ·áÁø ¸ðµÎ¿¡°Ô ¾îÇÊÇÒ ¼ö ÀÖ´Â Á¦Ç°À» °³¹ßÇϰí ÀÖ½À´Ï´Ù. °³¼±µÈ ¾Á µðÀÚÀÎ, Ç×±Õ ¼ÒÀç, ÄÄÆÑÆ®ÇÑ ±¸Á¶¿Í °°Àº Çõ½ÅÀº º¥Ãò¸® ¸¶½ºÅ©ÀÇ »ç¿ë ÆíÀǼº°ú À§»ýÀ» Çâ»ó½ÃÄÑ ÀÓ»ó ¹× ÀçÅÃÀÇ·á ȯ°æ ¸ðµÎ¿¡¼ ´õ ¸Å·ÂÀûÀ¸·Î ¸¸µé°í ÀÖ½À´Ï´Ù. ÀÇ·áÁø°ú ȯÀÚµéÀÌ »ê¼Ò ¿ä¹ý¿¡ ´ëÇÑ °íǰÁúÀÇ È¿°úÀûÀÎ ¼Ö·ç¼ÇÀ» ã´Â °¡¿îµ¥, ÀÌ·¯ÇÑ ¹ßÀüÀº º¥Ãò¸® ¸¶½ºÅ©¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¥Ãò¸® ¸¶½ºÅ© ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?
º¥Ãò¸® ¸¶½ºÅ© ½ÃÀåÀÇ ¼ºÀåÀº È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡, ÇコÄÉ¾î ±â¼úÀÇ ¹ßÀü, ÀçÅÃÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¸î °¡Áö ÁÖ¿ä ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ ¿äÀÎ Áß Çϳª´Â COPD ¹× õ½Ä°ú °°Àº ¸¸¼º È£Èí±âÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ÁúȯÀº ÅëÁ¦µÈ »ê¼Ò ¿ä¹ýÀ» ÅëÇØ È¿°úÀûÀ¸·Î °ü¸®ÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀÌ º¸Æíȵʿ¡ µû¶ó ÀÇ·áÁøÀº Á¤È®ÇÑ »ê¼Ò ³óµµ¸¦ Á¦°øÇϰí ȯÀÚÀÇ °á°ú¿Í »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â º¥Ãò¸® ¸¶½ºÅ©¿¡ Á¡Á¡ ´õ ¸¹Àº °ü½ÉÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù. ÀûÀýÇÑ »ê¼Ò ¿ä¹ýÀÌ È£Èí±âÁúȯ °ü¸®¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó º¥Ãò¸® ¸¶½ºÅ©ÀÇ ÀÓ»ó Àû¿ëÀÌ ´õ¿í °¡¼Óȵǰí ÀÖ½À´Ï´Ù.
ÀÇ·á ±â¼úÀÇ ¹ßÀüµµ º¥Ãò¸® ¸¶½ºÅ© ½ÃÀåÀÇ ¼ºÀå¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. µðÀÚÀÎ, ¼ÒÀç, Á¦Á¶ °øÁ¤ÀÇ Çõ½ÅÀ¸·Î º¸´Ù Æí¾ÈÇÏ°í »ç¿ëÇϱ⠽¬¿ì¸ç, Á¦¾îµÈ »ê¼Ò¸¦ È¿°úÀûÀ¸·Î °ø±ÞÇÒ ¼ö ÀÖ´Â º¥Ãò¸® ¸¶½ºÅ©°¡ ¸¸µé¾îÁö°í ÀÖ½À´Ï´Ù. °¢ Á¦Á¶¾÷üµéÀº ¹ÐÆó¼ºÀÌ ³ô°í °ø±â ´©ÃâÀ» ÃÖ¼ÒÈÇÏ´Â °¡º±°í ³»±¸¼ºÀÌ ¶Ù¾î³ ¸¶½ºÅ© °³¹ß¿¡ ÁÖ·ÂÇÏ¿© ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼ ¼º´ÉÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú °³¼±À¸·Î º¥Ãò¸® ¸¶½ºÅ©´Â ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎ¿¡°Ô ¸Å·ÂÀûÀÎ ¼±ÅÃÀÌ µÇ¾î º´¿ø, Áø·á¼Ò, ÀçÅÃÀÇ·á ȯ°æ¿¡¼ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.
ÀçÅÃÀÇ·á ¼ºñ½ºÀÇ È®´ëµµ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. Áý¿¡¼ È£Èí±âÁúȯÀ» °ü¸®Çϴ ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î »ê¼Ò °ø±Þ ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º¥Ãò¸® ¸¶½ºÅ©´Â º¹ÀâÇÑ ÀåÄ¡¸¦ ÇÊ¿ä·Î ÇÏÁö ¾Ê°í ¾ÈÁ¤ÀûÀ̰í Á¤È®ÇÑ »ê¼Ò °ø±ÞÀ» ½ÇÇöÇϱ⠶§¹®¿¡ ÀçÅÃÀÇ·á¿ëÀ¸·Î ÀûÇÕÇÕ´Ï´Ù. °í·ÉÈ »çȸ¿¡¼ È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÀçÅÃÀÇ·á ¼ºñ½ºÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖÀ¸¸ç, »ê¼Ò Ä¡·áÀÇ Ç¥ÁØ ±¸¼º¿ä¼Ò·Î¼ º¥Ãò¸® ¸¶½ºÅ©¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.
°¨¿° ¿¹¹æ°ú ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á ¼ºñ½º Á¦°øÀÚ´Â ÀÌÂ÷ ¿À¿°°ú °¨¿° À§ÇèÀ» ÃÖ¼ÒÈÇÏ´Â Àåºñ¸¦ äÅÃÇϰí ÀÖ½À´Ï´Ù. Ç×±Õ¼ºÀÌ ÀÖ°í ¼¼Ã´ÀÌ ¿ëÀÌÇÑ ¼ÒÀç·Î ¼³°èµÈ º¥Ãò¸® ¸¶½ºÅ©´Â ÀÇ·á ½Ã¼³¿¡¼ À§»ý°ú ¾ÈÀüÀ» ¿ì¼±½ÃÇÏ´Â ÇÁ·ÎÅäÄÝÀ» äÅÃÇÔ¿¡ µû¶ó Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. º´¿ø°ú Áø·á¼Ò°¡ º¸´Ù ¾ö°ÝÇÑ °¨¿° ¿¹¹æ Á¶Ä¡¸¦ ½ÃÇàÇÔ¿¡ µû¶ó ȯÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇÏ´Â °íǰÁú º¥Ãò¸® ¸¶½ºÅ©¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
°á·ÐÀûÀ¸·Î, ¼¼°è º¥Ãò¸® ¸¶½ºÅ© ½ÃÀåÀº È¿°úÀûÀÎ »ê¼Ò Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÇ·á ±â¼ú ¹ßÀü, ÀçÅÃÀÇ·á ¼ºñ½º È®´ë µîÀ¸·Î ÀÎÇØ °·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. È£Èí±âÁúȯÀÇ À¯º´·üÀÌ °è¼Ó Áõ°¡Çϰí ÀÇ·á ¼ºñ½º Á¦°øÀÚ°¡ »ê¼Ò °ø±ÞÀ» ÅëÁ¦ÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇØ ³ë·ÂÇÔ¿¡ µû¶ó º¥Ãò¸® ¸¶½ºÅ©´Â È£Èí±â Ä¡·á¿¡ ÀÖ¾î Áß¿äÇÑ ¿ä¼Ò·Î ³²À» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. º¥Ãò¸® ¸¶½ºÅ© ½ÃÀåÀº µðÀÚÀΰú ¼ÒÀçÀÇ Çõ½ÅÀÌ ÁøÇàµÊ¿¡ µû¶ó Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ºÎ¹®
¿ëµµ(COPD, õ½Ä, ±âŸ ¿ëµµ)
AI ÅëÇÕ
Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå°ú °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.
Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.
°ü¼¼ ¿µÇâ °è¼ö
Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Global Venturi Masks Market to Reach US$5.9 Billion by 2030
The global market for Venturi Masks estimated at US$3.1 Billion in the year 2024, is expected to reach US$5.9 Billion by 2030, growing at a CAGR of 11.5% over the analysis period 2024-2030. COPD, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$2.9 Billion by the end of the analysis period. Growth in the Asthma segment is estimated at 10.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$778.1 Million While China is Forecast to Grow at 15.7% CAGR
The Venturi Masks market in the U.S. is estimated at US$778.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 15.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 9.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.
Global Venturi Masks Market - Key Trends & Drivers Summarized
What Are Venturi Masks and How Are They Manufactured?
Venturi masks are medical devices designed to deliver a precise concentration of oxygen to patients with respiratory conditions. Unlike standard oxygen masks, Venturi masks utilize a unique design that incorporates a Venturi effect to mix ambient air with oxygen, allowing for controlled oxygen delivery based on the patient's needs. This makes them particularly effective for patients requiring a specific fraction of inspired oxygen (FiO2), such as those with chronic obstructive pulmonary disease (COPD), asthma, or other respiratory illnesses. The ability to provide accurate oxygen concentrations makes Venturi masks a preferred choice in clinical settings, including hospitals and outpatient care facilities.
The manufacturing of Venturi masks involves the creation of a mask body, typically made from lightweight, durable plastics, and the incorporation of various colored adapters that determine the oxygen flow rates. Each adapter has a specific orifice size, allowing for the mixing of different amounts of ambient air with the delivered oxygen. The design must ensure a tight seal around the patient’s face to prevent the escape of exhaled air while facilitating the flow of oxygen. The masks are usually produced using injection molding processes, which enable manufacturers to create uniform and reliable components that meet stringent medical standards.
Recent advancements in the design and manufacturing of Venturi masks focus on improving patient comfort, enhancing oxygen delivery efficiency, and integrating modern materials that reduce weight while maintaining durability. Innovations include soft silicone or gel liners that provide a better fit and seal against the face, improving the overall comfort for extended use. Manufacturers are also exploring the use of antimicrobial materials to reduce the risk of infections associated with long-term mask use. Additionally, there is a trend toward the development of more compact and portable Venturi masks, making them easier to use in various settings, including home care environments.
What Are the Primary Applications of Venturi Masks Across Industries?
Venturi masks are primarily used in the healthcare industry, particularly in hospitals, outpatient clinics, and home care settings, for the management of patients with respiratory conditions. One of the main applications of Venturi masks is in the treatment of patients with chronic obstructive pulmonary disease (COPD), where maintaining optimal oxygen levels is crucial. By delivering a controlled concentration of oxygen, Venturi masks help prevent exacerbations of the condition, allowing patients to breathe more easily and improve their overall quality of life. This precise oxygen delivery reduces the risks associated with both hypoxia and hyperoxia, making Venturi masks an essential tool in managing COPD.
In emergency medical situations, Venturi masks are employed to provide oxygen therapy to patients experiencing acute respiratory distress or exacerbations of asthma and pneumonia. The ability to deliver specific oxygen concentrations quickly and effectively is vital in emergency care settings, where rapid intervention can significantly impact patient outcomes. Venturi masks are also used during transport for patients requiring oxygen therapy, as they provide a reliable and stable source of oxygen without the need for complex equipment. This makes them an invaluable asset in ambulances and critical care transport services.
Furthermore, Venturi masks are increasingly being utilized in home healthcare settings for patients with chronic respiratory conditions. As more individuals receive care at home, the demand for portable and easy-to-use oxygen delivery devices has grown. Venturi masks are favored in home care because they offer precise control over oxygen concentrations, allowing patients to manage their respiratory conditions effectively without frequent visits to healthcare facilities. The rising prevalence of respiratory diseases and the growing aging population are contributing to the increased adoption of Venturi masks in home healthcare.
Venturi masks are also being incorporated into research and clinical studies to evaluate new treatments and therapies for respiratory conditions. Their ability to deliver controlled oxygen concentrations allows researchers to study the effects of different oxygen levels on various respiratory diseases and treatments. This application is particularly important as the medical community seeks to understand the optimal management of chronic conditions and the development of new therapeutic approaches.
Why Is Consumer Demand for Venturi Masks Increasing?
The demand for Venturi masks is increasing due to several factors, including the rising prevalence of respiratory diseases, growing awareness of the importance of controlled oxygen therapy, and the expansion of home healthcare services. One of the primary drivers of demand is the increasing incidence of chronic respiratory conditions, such as COPD and asthma. As these conditions become more prevalent, particularly among aging populations, the need for effective oxygen delivery systems that can provide precise control over oxygen levels is growing. Venturi masks offer a solution by delivering targeted oxygen therapy, making them a vital tool in the management of these chronic diseases.
The growing emphasis on patient-centered care and the importance of maintaining optimal oxygen saturation levels have also contributed to the rising demand for Venturi masks. Healthcare providers are increasingly recognizing the value of delivering controlled oxygen therapy, as it minimizes the risk of complications associated with both under-oxygenation and over-oxygenation. Venturi masks, with their ability to provide accurate and adjustable oxygen concentrations, are becoming a preferred choice in clinical practice. As awareness of the benefits of controlled oxygen delivery continues to rise, the adoption of Venturi masks is expected to grow.
Additionally, the expansion of home healthcare services is driving demand for Venturi masks. As more patients receive care in their own homes, there is an increasing need for portable and user-friendly medical devices that allow for effective management of respiratory conditions. Venturi masks are well-suited for home care applications due to their simplicity and reliability in providing controlled oxygen therapy. This trend is particularly important in light of the COVID-19 pandemic, which has led to a significant increase in the number of patients being managed at home. The demand for effective oxygen delivery solutions in home care settings is expected to boost the market for Venturi masks.
Technological advancements in the design and materials used in Venturi masks are also contributing to their growing popularity. Manufacturers are developing masks that are more comfortable, lightweight, and easy to use, which appeals to both patients and healthcare providers. Innovations such as improved seal designs, antimicrobial materials, and compact structures enhance the usability and hygiene of Venturi masks, making them more attractive in both clinical and home healthcare environments. These advancements are expected to further drive the demand for Venturi masks as healthcare providers and patients seek high-quality, effective solutions for oxygen therapy.
What Factors Are Driving the Growth of the Venturi Masks Market?
The growth of the Venturi masks market is driven by several key factors, including the increasing prevalence of respiratory diseases, advancements in healthcare technology, and the rising focus on home healthcare solutions. One of the most significant factors is the growing incidence of chronic respiratory conditions, such as COPD and asthma, which require effective management through controlled oxygen therapy. As these conditions become more common, healthcare providers are increasingly turning to Venturi masks to deliver precise oxygen concentrations, improving patient outcomes and quality of life. The increasing awareness of the impact of proper oxygen therapy on managing respiratory diseases is further driving the adoption of Venturi masks in clinical settings.
Advancements in medical technology are also playing a crucial role in the growth of the Venturi masks market. Innovations in design, materials, and manufacturing processes have resulted in Venturi masks that are more comfortable, user-friendly, and effective in delivering controlled oxygen. Manufacturers are focusing on creating lightweight, durable masks that provide better seals and minimize air leakage, enhancing their performance in various healthcare settings. These technological improvements are making Venturi masks a more appealing option for healthcare providers and patients alike, driving their adoption across hospitals, clinics, and home healthcare environments.
The expansion of home healthcare services is another significant factor contributing to market growth. As more patients manage their respiratory conditions at home, the demand for effective and easy-to-use oxygen delivery devices is increasing. Venturi masks are well-suited for home care applications, as they offer reliable and precise oxygen delivery without the need for complex equipment. The rising prevalence of respiratory diseases in aging populations is also fueling the growth of home healthcare services, further boosting the demand for Venturi masks as a standard component of oxygen therapy.
The increasing focus on infection control and patient safety is driving healthcare providers to adopt devices that minimize the risk of cross-contamination and infection. Venturi masks designed with antimicrobial properties and easy-to-clean materials are gaining traction as healthcare facilities prioritize hygiene and safety in their protocols. As hospitals and clinics implement more stringent infection control measures, the demand for high-quality Venturi masks that ensure patient safety is expected to grow.
In conclusion, the global Venturi masks market is poised for robust growth, driven by rising demand for effective oxygen therapy solutions, advancements in medical technology, and the expansion of home healthcare services. As the prevalence of respiratory diseases continues to rise and healthcare providers seek to improve patient outcomes through controlled oxygen delivery, Venturi masks will remain a critical component in respiratory care. With ongoing innovations in design and materials, the market for Venturi masks is expected to experience sustained expansion in the coming years.
SCOPE OF STUDY:
The report analyzes the Venturi Masks market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Application (COPD, Asthma, Other Applications)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 42 Featured) -
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.